¼¼°èÀÇ ÇコÄɾî IT ½ÃÀå
Healthcare IT
»óǰÄÚµå : 1770148
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 1205 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,112,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,338,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇコÄɾî IT ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7,768¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 4,087¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇコÄɾî IT ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 11.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7,768¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®Çϰí ÀÖ´Â ºÎ¹® Áß ÇϳªÀÎ ¼­ºñ½º´Â CAGR 11.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 4,344¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 11.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 1,485¾ï ´Þ·¯, Áß±¹Àº CAGR 16.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄɾî IT ½ÃÀåÀº 2024³â¿¡ 1,485¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 561¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 16.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 9.2%¿Í 10.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 10.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÇコÄɾî IT ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÇコÄɾî Á¤º¸±â¼ú(ÇコÄɾî IT)Àº ÀÇ·áÁ¤º¸ÀÇ ÀúÀå, °øÀ¯, ºÐ¼®¿¡ »ç¿ëµÇ´Â ±¤¹üÀ§ÇÑ ±â¼úÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú¿¡´Â ÀüÀڰǰ­±â·Ï(EHR), ¿ø°ÝÀÇ·á Ç÷§Æû, °Ç°­Á¤º¸±³È¯(HIE), ´Ù¾çÇÑ °Ç°­ ºÐ¼® µµ±¸ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÇコÄɾî IT´Â ȯÀÚ Á¤º¸¿¡ ´ëÇÑ ¿øÈ°ÇÑ Á¢±ÙÀ» °¡´ÉÇÏ°Ô Çϰí, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» ÃËÁøÇÏ¿© ȯÀÚ Ä¡·á °³¼±, ¾÷¹« È¿À²¼º Çâ»ó, ÀÇ·á ºñ¿ë Àý°¨À» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, EHRÀº ȯÀÚÀÇ º´·ÂÀ» µðÁöÅÐÈ­ÇÑ °ÍÀ¸·Î, ´Ù¸¥ ÀÇ·á ȯ°æ¿¡¼­µµ ½ÂÀÎµÈ »ç¿ëÀÚ°¡ °ü·Ã µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¿ø°ÝÀÇ·á Ç÷§ÆûÀº ¿ø°ÝÁø·á¸¦ °¡´ÉÇÏ°Ô Çϰí, ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϸç, ȯÀÚÀÇ ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÇ·á IT ½Ã½ºÅÛÀº ¶ÇÇÑ µ¥ÀÌÅÍ ºÐ¼® ¹× Áõ°Å ±â¹Ý Áø·á¸¦ À§ÇÑ µµ±¸¸¦ Á¦°øÇÔÀ¸·Î½á ÀÓ»ó ÀÇ»ç°áÁ¤À» Áö¿øÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ÇコÄɾî IT ¼Ö·ç¼ÇÀÇ °³¹ß°ú º¸±ÞÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃÀÇ Çõ½ÅÀº È®Àå °¡´ÉÇÏ°í ¾ÈÀüÇÑ µ¥ÀÌÅÍ ÀúÀåÀ» °¡´ÉÇÏ°Ô ÇÏ¿© EHR°ú HIEÀÇ ±¤¹üÀ§ÇÑ µµÀÔÀ» ÃËÁøÇß½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)Àº ÇコÄɾî IT ½Ã½ºÅÛ¿¡ ÅëÇÕµÇ¾î ¿¹Ãø ºÐ¼®À» Á¦°øÇϰí, ÀÓ»óÀû ÀÇ»ç°áÁ¤À» Áö¿øÇϸç, ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á´Â ºü¸£°Ô ¹ßÀüÇϰí ÀÖÀ¸¸ç, °íÇØ»óµµ È­»ó ȸÀÇ, ¿ø°Ý ¸ð´ÏÅ͸µ ±â±â, ¸ð¹ÙÀÏ Çコ ¾ÖÇø®ÄÉÀ̼ÇÀ» ÅëÇØ °¡»ó Áø·áÀÇ Áú°ú ¹üÀ§°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. »çÀ̹ö º¸¾È ´ëÃ¥µµ ¹ßÀüÇÏ¿© ¹Î°¨ÇÑ ÀÇ·á Á¤º¸°¡ Ä§ÇØ ¹× ¹«´Ü ¾×¼¼½º·ÎºÎÅÍ ¾ÈÀüÇÏ°Ô º¸È£µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ÀÇ·á ¼­ºñ½º¸¦ º¸´Ù È¿À²ÀûÀ̰í, °³ÀÎÈ­µÇ°í, Á¢±ÙÇϱ⠽¬¿î ¹æ½ÄÀ¸·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù.

ÇコÄɾî IT ½ÃÀåÀÇ ¼ºÀåÀº ÷´Ü ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÇコÄɾî IT µµÀÔÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ ³ë·Â, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½ºÀÇ Áú°ú È¿À²¼ºÀ» Çâ»ó½ÃÄÑ¾ß ÇÑ´Ù´Â Çʿ伺¿¡ µû¶ó ÀÇ·á IT ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, HITECH(Health Information Technology for Economic and Clinical Health) ¹ý°ú °°Àº Á¤ºÎ Á¤Ã¥ ¹× Àμ¾Æ¼ºê°¡ EHR ¹× ±âŸ ÀÇ·á IT ½Ã½ºÅÛ µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê°ú °í·ÉÈ­·Î ÀÎÇØ »çÀü ¿¹¹æÀûÀ̰í Çù·ÂÀûÀÎ Ä¡·á¸¦ Áö¿øÇÏ´Â ÀÇ·á IT ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19´Â ¿ø°ÝÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­ÇÏ¿© µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ Á߿伺À» °­Á¶Çϰí ÀÖÀ¸¸ç, AI, ML, Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú °°Àº ±â¼úÀÇ ¹ßÀüÀº Çõ½ÅÀûÀÎ ÀÇ·á IT ¾ÖÇø®ÄÉÀ̼ÇÀÇ °³¹ß ¹× ¹èÆ÷¸¦ ÃËÁøÇÏ°í ½ÃÀå È®ÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

±¸¼º¿ä¼Ò(¼­ºñ½º, ¼ÒÇÁÆ®¿þ¾î, Çϵå¿þ¾î), ¼Ö·ç¼Ç(¼öÀÍ Áֱ⠰ü¸®, ÀüÀڰǰ­±â·Ï, ¸ð¹ÙÀÏ Çコ, ÇコÄÉ¾î ºÐ¼®, ÅÚ·¹Çコ, °í°´°ü°è°ü¸®, °ø±Þ¸Á °ü¸®, ±âŸ ¼Ö·ç¼Ç), ÃÖÁ¾»ç¿ëÀÚ(ÀÇ·á Á¦°øÀÚ, ÀÇ·áºñ ÁöºÒÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Healthcare IT Market to Reach US$776.8 Billion by 2030

The global market for Healthcare IT estimated at US$408.7 Billion in the year 2024, is expected to reach US$776.8 Billion by 2030, growing at a CAGR of 11.3% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$434.4 Billion by the end of the analysis period. Growth in the Software segment is estimated at 11.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$148.5 Billion While China is Forecast to Grow at 16.1% CAGR

The Healthcare IT market in the U.S. is estimated at US$148.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$56.1 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 10.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global Healthcare IT Market - Key Trends & Drivers Summarized

Healthcare Information Technology (Healthcare IT) encompasses a wide range of technologies used to store, share, and analyze health information. These technologies include electronic health records (EHRs), telemedicine platforms, health information exchanges (HIEs), and various health analytics tools. Healthcare IT aims to improve patient care, enhance operational efficiency, and reduce healthcare costs by enabling seamless access to patient information and facilitating communication between healthcare providers. EHRs, for instance, provide a digital version of a patient's medical history, ensuring that relevant data is available to authorized users across different healthcare settings. Telemedicine platforms allow for remote consultations, expanding access to care and improving patient convenience. Health IT systems also support clinical decision-making by providing tools for data analysis and evidence-based practice.

Technological advancements have significantly propelled the development and adoption of healthcare IT solutions. Innovations in cloud computing have enabled scalable and secure data storage, facilitating the widespread implementation of EHRs and HIEs. Artificial intelligence (AI) and machine learning (ML) are increasingly being integrated into healthcare IT systems to provide predictive analytics, support clinical decision-making, and improve patient outcomes. Telemedicine has seen rapid advancements, with high-definition video conferencing, remote monitoring devices, and mobile health applications enhancing the quality and reach of virtual care. Cybersecurity measures have also evolved, ensuring that sensitive health information is protected from breaches and unauthorized access. These technological advancements are transforming healthcare delivery, making it more efficient, personalized, and accessible.

The growth in the healthcare IT market is driven by several factors, including the increasing demand for advanced healthcare solutions, government initiatives to promote health IT adoption, and the rising prevalence of chronic diseases. The need to improve the quality and efficiency of healthcare services has led to significant investments in health IT infrastructure. Government policies and incentives, such as the Health Information Technology for Economic and Clinical Health (HITECH) Act, have encouraged the adoption of EHRs and other health IT systems. The growing prevalence of chronic diseases and the aging population have further fueled the demand for health IT solutions that support proactive and coordinated care. Additionally, the COVID-19 pandemic has accelerated the adoption of telemedicine and remote monitoring technologies, highlighting the importance of digital health solutions. Technological advancements, such as AI, ML, and cloud computing, are also driving the development and deployment of innovative health IT applications, supporting the market's expansion.

SCOPE OF STUDY:

The report analyzes the Healthcare IT market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Services, Software, Hardware); Solution (Revenue Cycle Management, Electronic Health Record, mHealth, Healthcare Analytics, Telehealth, Customer Relationship Management, Supply Chain Management, Other Solutions); End-Use (Healthcare Providers, Healthcare Payers)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 353 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â